TDM MPA

Therapeutic Drug Monitoring of Mycophenolic Acid Chow YW Hospital Kuala Lumpur

MPA therapies ,[object Object],[object Object]

MOA of MPA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MPA TDM use is not widespread ,[object Object],[object Object],[object Object],[object Object]

MPA pharmacokinetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MPA pharmacokinetics ,[object Object],[object Object],[object Object]

MPA pharmacokinetics ,[object Object],[object Object]

Renal dysfunction ,[object Object],[object Object],[object Object],[object Object]

Liver Dysfunction ,[object Object],[object Object],[object Object]

Other facts ,[object Object],[object Object],[object Object],[object Object],[object Object]

MPA exposure and Clinical Outcomes ,[object Object],[object Object],[object Object],[object Object]

MPA exposure and Clinical Outcomes ,[object Object],[object Object],[object Object],[object Object],[object Object]

TDM usefulness ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Guidelines for TDM ,[object Object],[object Object],[object Object],[object Object]

Recommended